BOW MEDICAL PRACTICE
ITER CROSS, BOW, CREDITON
HF003
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, the percentage of patients who are currently treated with an ACE-I or ARB
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 3 | 2010 | 6 | 7 | 85.7% | |
| HF 3 | 2011 | 6 | 6 | 100.0% | |
| HF 3 | 2012 | 9 | 10 | 90.0% | |
| HF 3 | 2013 | 13 | 15 | 86.7% | |
| HF003 | 2014 | 10 | 10 | 100.0% | |
| HF003 | 2015 | 10 | 10 | 100.0% | |
| HF003 | 2016 | 17 | 17 | 100.0% | |
| HF003 | 2017 | 17 | 17 | 100.0% | |
| HF003 | 2018 | 16 | 16 | 100.0% | |
| HF003 | 2019 | 15 | 15 | 100.0% | |
| HF003 | 2020 | 18 | 18 | 100.0% | |
| HF003 | 2021 | 16 | 20 | 80.0% | |
| HF003 | 2022 | 14 | 14 | 100.0% | |
| HF003 | 2023 | 18 | 18 | 100.0% |
